These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Status of chemotherapy in inoperable non-small cell bronchial carcinoma]. Brunner KW; Joss R; Goldhirsch A Schweiz Rundsch Med Prax; 1983 Aug; 72(32):1057-62. PubMed ID: 6622423 [No Abstract] [Full Text] [Related]
5. Combination chemotherapy for non-small cell bronchogenic carcinoma with bleomycin, doxorubicin, methotrexate, and cis-dichlorodiammineplatinum(II) (BAMP). Vogl SE; Wollner D; Kaplan BH; Berenzweig M Cancer Treat Rep; 1980; 64(4-5):717-9. PubMed ID: 6159081 [No Abstract] [Full Text] [Related]
6. [Cytostatic treatment of inoperable and after care of operable bronchial cancer]. Niederle N; Seeber S Prax Klin Pneumol; 1982 Jul; 36(7):305-11. PubMed ID: 6287448 [No Abstract] [Full Text] [Related]
7. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma. Vogelzang NJ; Bonomi PD; Rossof AH; Wolter J Cancer Treat Rep; 1978 Oct; 62(10):1595-7. PubMed ID: 709563 [No Abstract] [Full Text] [Related]
8. Some thoughts on surgical adjuvant studies in lung cancer. Carter SK Cancer Chemother Rep 3; 1973 Mar; 4(2):109-17. PubMed ID: 4729314 [No Abstract] [Full Text] [Related]
10. [Chemotherapy of bronchopulmonary cancer. Trial of the BACON protocol]. Adenis L; Restellini J; Caty A LARC Med; 1981 Nov; 1(2):50-1. PubMed ID: 6188012 [No Abstract] [Full Text] [Related]
11. [Prognostic factors in the chemotherapy of bronchial cancers]. Alberto P Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755 [No Abstract] [Full Text] [Related]
12. [Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)]. Dundalek E Prax Klin Pneumol; 1980 Dec; 34(12):719-23. PubMed ID: 7465532 [No Abstract] [Full Text] [Related]
13. Chemotherapeutic studies in bronchogenic carcinoma by the Austrian study group. Karrer K; Pridun N; Zwintz E Cancer Chemother Rep 3; 1973 Mar; 4(2):207-13. PubMed ID: 4729324 [No Abstract] [Full Text] [Related]
14. [Polychemotherapeutic treatment of pulmonary neoplasms]. Dorigoni A; Peris GC; Scarponi F; Alcozer G G Pneumol; 1970 Jun; 14(3):164-92. PubMed ID: 5526216 [No Abstract] [Full Text] [Related]
15. Remission rates, survival, and prognostic factors in combination chemotherapy for bronchogenic carcinoma. Alberto P Cancer Chemother Rep 3; 1973 Mar; 4(2):199-206. PubMed ID: 4729321 [No Abstract] [Full Text] [Related]
16. [Clinical study of the secondary toxicity, effective responses and survival time in the treatment of primary non-microcytic (NSCLC) carcinoma of the lung with various polychemotherapy regimens]. Carminati F; Maccone C; De Marinis F Clin Ter; 1982 May; 101(3):221-7. PubMed ID: 6284434 [No Abstract] [Full Text] [Related]
17. [Chemotherapy of bronchial cancer: promise or reality?]. Kleinman S Rev Med Chil; 1981 Sep; 109(9):885-6. PubMed ID: 6281873 [No Abstract] [Full Text] [Related]
18. Hexamethylmelamine in inoperable bronchogenic carcinoma. Takita H N Y State J Med; 1972 Feb; 72(4):477-80. PubMed ID: 4334448 [No Abstract] [Full Text] [Related]
19. [Cytostatic therapy of tumors of the lung]. De Marco F; Saviano G; Tenore G Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917 [No Abstract] [Full Text] [Related]